pink@2x

PRESENTED BY

Bio-Deutschland Lopgo
Euronext Logo
Labiotech.eu Logo

Entrepreneurship has always been and still is a driving force in the development of the German biotechnology industry. BIO Deutschland thus provides Start-ups with opportunities to present their ideas and business concepts as well as network at various events and conferences. 

The German Biotech Startup Report 2017 has been created In cooperation with Labiotech and with the support of Euronext. BIO Deutschland aims to create an internet-portal for the German biotech startup scene, which  features in-depth article(s), as well as company profiles of German biotech start-ups founded in most recent years.

Germany and the Biotech Startup Community

In recent years, Germany’s biotech sector has experienced a period of economic growth and stability. This is mirrored in a 2016 record turnover of €3.5bn ($4.1bn), as well as a higher number of employees in German biotech companies, which at 18,000 employees was significantly higher than in 2015 (with 15,000 employees). Where there were 591 biotech firms in 2015, Germany counted a new total of 623 companies, including 15 new startups in 2016. Of these 623 companies, approximately 81% are small and medium-sized enterprises (SMEs). What

Read the Article »

German Biotech Startups

Company profile Assay.Works

Assay.Works mission is to accelerate their partner’s research programs by developing and executing predictive and scalable assays to quantify the

View Profile »
Company profile UGISense

The proprietary antisense technology developed by UGISense AG overcomes the drawbacks of standard antisense technologies. Together with industrial partners, they

View Profile »
Company profile NUMAFERM

NUMAFERM is a pioneer in the production of recombinant peptides. By lowering production costs significantly, they are going to make

View Profile »
Company profile PreOmics

PreOmics develops and provides innovative technologies for customers around the world from mass spectrometry-based proteomics to support researchers in their

View Profile »
Company profile TolerogenixX

TolerogenixX has a patented technology that can be used to suppress unwanted immune responses in the body. This novel cell therapy

View Profile »
Company profile Avergen

Avergen seeks to find new treatments for cancer. They are establishing a drug discovery platform for protein-to-protein interaction inhibitors. The advantage

View Profile »
Company profile Cenata

Cenata is available as a partner in all matters relating to genetic prenatal diagnosis, non-invasive prenatal testing (NIPT), and interpretation

View Profile »
Company profile Cellbricks

Cellbricks is a specialist in bioprinting, which allows the three-dimensional printing of biological material. Driven by the vision to advance

View Profile »
Company profile Upcyte Technologies

This company’s vision is to establish Upcyte Technologies as the gold standard and preferred source of cell-based products for research

View Profile »
Company profile Immunic Therapeutics

Immunic AG develops immune modulators to block TH17, TH1-mediated immune drawbacks, and autoimmune responses. Their main goal is to develop

View Profile »
Company profile Heidelberg ImmunoTherapeutics

This company is translating innovative science into successful immunotherapeutic approaches. Heidelberg ImmunoTherapeutics is a clinical stage company dedicated to the

View Profile »
Company profile Cardior

Cardior is developing a proprietary RNA technology to revolutionize heart failure treatment. This company aims to be the international leader

View Profile »
Company profile Sulfotools

With their Clean Peptide technology, Sulfotools is revolutionizing the over 40-year-old process of peptide synthesis, making it more sustainable and eco-friendly.

View Profile »
Company profile iOmx Therapeutics

This startup is developing next-generation cancer immunotherapies targeting novel immune evasion pathways. iOmx focuses on the development of first-in-class cancer

View Profile »

This is only the beginning...

There's more to come in 2018! Updates, additional profiles, new reports!

Let us know if you want us to let you know once there are updates.